Cabot (CBT)
(Delayed Data from NYSE)
$104.24 USD
+2.86 (2.82%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $104.35 +0.11 (0.11%) 7:58 PM ET
2-Buy of 5 2
A Value A Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$104.24 USD
+2.86 (2.82%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $104.35 +0.11 (0.11%) 7:58 PM ET
2-Buy of 5 2
A Value A Growth A Momentum A VGM
Zacks News
Innospec Inc. (IOSP) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Innospec (IOSP) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Cabot (CBT) Is Up 0.56% in One Week: What You Should Know
by Zacks Equity Research
Does Cabot (CBT) have what it takes to be a top stock pick for momentum investors? Let's find out.
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
3 Reasons Growth Investors Will Love Cabot (CBT)
by Zacks Equity Research
Cabot (CBT) could produce exceptional returns because of its solid growth attributes.
Are Basic Materials Stocks Lagging Agnico Eagle Mines (AEM) This Year?
by Zacks Equity Research
Here is how Agnico Eagle Mines (AEM) and Cabot (CBT) have performed compared to their sector so far this year.
Cabot's (CBT) Earnings Top Estimates in Q2, Revenues Lag
by Zacks Equity Research
The rise in EBIT across Cabot's (CBT) segments is partly due to higher volumes in Q2.
Cabot (CBT) Surpasses Q2 Earnings Estimates
by Zacks Equity Research
Cabot (CBT) delivered earnings and revenue surprises of 7.23% and 3.33%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Cabot (CBT) Chosen for $5M DOE Grant to Aid Hydrogen Economy
by Zacks Equity Research
Cabot (CBT) and its partners will utilize this money to help the implementation of fuel cells, which generate electricity by emitting only water.
Here's Why Cabot (CBT) is a Strong Value Stock
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why Cabot (CBT) is a Top Value Stock for the Long-Term
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Strength Seen in Compass (CMP): Can Its 13.3% Jump Turn into More Strength?
by Zacks Equity Research
Compass (CMP) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Cabot (CBT) Offers PROPEL E8 Tailored Reinforcing Carbon Black
by Zacks Equity Research
Cabot's (CBT) PROPEL E series is made up of high surface area and medium structure reinforcing carbon blacks that are engineered to increase the overall sustainability of the tire value chain.
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Cabot (CBT) Up 11.4% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Cabot (CBT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why Cabot (CBT) is a Top Momentum Stock for the Long-Term
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Cabot's (CBT) Earnings and Revenues Beat Estimates in Q1
by Zacks Equity Research
The rise in Cabot's (CBT) Reinforcement Materials segment's EBIT is primarily driven by greater unit margins resulting from increased pricing and product mix in Q1.
Are You Looking for a High-Growth Dividend Stock?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Cabot (CBT) have what it takes? Let's find out.
Koppers (KOP) Shares Surge 30% in 3 Months: What's Driving It?
by Zacks Equity Research
Koppers' (KOP) rally reflects a solid financial performance, driven by impressive growth in the Railroad and Utility Products and Services and Performance Chemicals segments.
Here's Why You Should Add DuPont (DD) to Your Portfolio Now
by Zacks Equity Research
DuPont (DD) benefits from innovation, the Spectrum Plastics acquisition and pricing and productivity actions.
Eastman Chemical (EMN) Shares Pop 17% in 3 Months: Here's Why
by Zacks Equity Research
Eastman Chemical (EMN) gains on cost-management actions and innovation and maintains a disciplined approach to capital allocation.
Best Value Stocks to Buy for January 15th
by Zacks Equity Research
RGA, PAX and CBT made it to the Zacks Rank #1 (Strong Buy) value stocks list on January 15, 2024.
Arkema (ARKAY) Backs Tiamat for Lithium-Free Battery Innovation
by Zacks Equity Research
Arkema (ARKAY) invests in Tiamat, accelerating the development of lithium-free solutions and supporting the construction of a dedicated 5 GWh Giga-factory in France.
New Strong Buy Stocks for January 15th
by Zacks Equity Research
CBT, BROS, WRK, ROCK and CBOE have been added to the Zacks Rank #1 (Strong Buy) List on January 15, 2024.
Daqo (DQ) Issues Update on $700M Share Repurchase Program
by Zacks Equity Research
Daqo New Energy (DQ) repurchased shares worth $491 million by 2023 end, expressing confidence in undervaluation and emphasizing capital preservation amid industry challenges.